• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可药物结合的硫氧还蛋白还原酶热点:DRUGpy 揭示的新药发现的新见解和机会。

Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy.

机构信息

Laboratorio de Cristalografia de Proteínas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto - USP, Address Av. do Café, s/n - Vila Monte Alegre, SP, 14040-903, Ribeirão Preto, Brazil.

Programa de pós-graduação em Ciências Farmacêuticas da UEFS, Feira de santana, Brazil.

出版信息

J Comput Aided Mol Des. 2021 Aug;35(8):871-882. doi: 10.1007/s10822-021-00403-8. Epub 2021 Jun 28.

DOI:10.1007/s10822-021-00403-8
PMID:34181199
Abstract

Assessment of target druggability guided by search and characterization of hot spots is a pivotal step in early stages of drug-discovery. The raw output of FTMap provides the data to perform this task, but it relies on manual intervention to properly combine different sets of consensus sites, therefore allowing identification of hot spots and evaluation of strength, shape and distance among them. Thus, the user's previous experience on the target and the software has a direct impact on how data generated by FTMap server can be explored. DRUGpy plugin was developed to overcome this limitation. By automatically assembling and scoring all possible combinations of consensus sites, DRUGpy plugin provides FTMap users a straight-forward method to identify and characterize hot spots in protein targets. DRUGpy is available in all operating systems that support PyMOL software. DRUGpy promptly identifies and characterizes pockets that are predicted by FTMap to bind druglike molecules with high-affinity (druggable sites) or low-affinity (borderline sites) and reveals how protein conformational flexibility impacts on the target's druggability. The use of DRUGpy on the analysis of trypanothione reductases (TR), a validated drug target against trypanosomatids, showcases the usefulness of the plugin, and led to the identification of a druggable pocket in the conserved dimer interface present in this class of proteins, opening new perspectives to the design of selective inhibitors.

摘要

基于热点搜索和特征描述的靶标可药性评估是药物发现早期阶段的关键步骤。FTMap 的原始输出提供了执行此任务的数据,但它依赖于手动干预来正确组合不同的共识位点集,从而能够识别热点并评估它们之间的强度、形状和距离。因此,用户在目标和软件方面的先前经验直接影响如何探索 FTMap 服务器生成的数据。DRUGpy 插件就是为了克服这一局限性而开发的。通过自动组装和评分所有可能的共识位点组合,DRUGpy 插件为 FTMap 用户提供了一种直接的方法来识别和描述蛋白质靶标中的热点。DRUGpy 可在支持 PyMOL 软件的所有操作系统上使用。DRUGpy 可以快速识别和描述那些被 FTMap 预测为与类药性分子具有高亲和力(可成药性位点)或低亲和力(边缘性位点)结合的口袋,并揭示蛋白质构象灵活性如何影响靶标可成药性。在对三磷酸鸟苷还原酶(TR)的分析中使用 DRUGpy,这是一种针对原生动物的已验证药物靶标,展示了该插件的有用性,并确定了在这类蛋白质中保守二聚体界面上存在的一个可成药性口袋,为设计选择性抑制剂开辟了新的前景。

相似文献

1
Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy.可药物结合的硫氧还蛋白还原酶热点:DRUGpy 揭示的新药发现的新见解和机会。
J Comput Aided Mol Des. 2021 Aug;35(8):871-882. doi: 10.1007/s10822-021-00403-8. Epub 2021 Jun 28.
2
Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.克氏锥虫的锥虫硫醇还原酶与锥虫硫醇复合物的晶体结构以及基于该结构发现新型天然产物抑制剂
Structure. 1999 Jan 15;7(1):81-9. doi: 10.1016/s0969-2126(99)80011-2.
3
Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.与大型酶口袋的结合:锥虫硫醇还原酶的小分子抑制剂
ChemMedChem. 2014 Aug;9(8):1880-91. doi: 10.1002/cmdc.201402032. Epub 2014 Apr 30.
4
Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites.扩展 FTMap 以基于片段的方法鉴定配体结合位点中的药效基团区域。
J Chem Inf Model. 2024 Mar 25;64(6):2084-2100. doi: 10.1021/acs.jcim.3c01969. Epub 2024 Mar 8.
5
Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.锥虫硫醇和谷胱甘肽还原酶中杀锥虫芳氧基醌的结构分析与分子对接:与生化数据的比较
J Biomol Struct Dyn. 2017 Jun;35(8):1785-1803. doi: 10.1080/07391102.2016.1195283. Epub 2016 Jul 15.
6
Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.从高通量筛选中鉴定和结合新型利什曼原虫硫氧还蛋白还原酶抑制剂。
PLoS Negl Trop Dis. 2018 Nov 26;12(11):e0006969. doi: 10.1371/journal.pntd.0006969. eCollection 2018 Nov.
7
Parasite-specific trypanothione reductase as a drug target molecule.寄生虫特异性的锥虫硫醇还原酶作为一种药物靶点分子。
Parasitol Res. 2003 Jun;90 Suppl 2:S77-85. doi: 10.1007/s00436-002-0771-8. Epub 2003 Apr 23.
8
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.使用傅里叶域相关技术基于片段鉴定蛋白质的可成药“热点”
Bioinformatics. 2009 Mar 1;25(5):621-7. doi: 10.1093/bioinformatics/btp036. Epub 2009 Jan 28.
9
Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis.靶向硕大利什曼原虫的锥虫硫醇还原酶以对抗皮肤利什曼病
Infect Disord Drug Targets. 2019;19(4):388-393. doi: 10.2174/1871526518666180502141849.
10
Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.通过筛选和化学合成改进的锥虫硫醇还原酶三环抑制剂
ChemMedChem. 2009 Aug;4(8):1333-40. doi: 10.1002/cmdc.200900097.

引用本文的文献

1
Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural Analyses.通过分子动力学模拟和结构分析揭示克鲁兹蛋白酶之间的常见模式和差异
ACS Omega. 2025 May 2;10(18):19115-19128. doi: 10.1021/acsomega.5c01876. eCollection 2025 May 13.
2
An and investigation of the antitrypanosomal activities of the stem bark extracts of (Pierre) Engl.对(皮埃尔)恩格勒茎皮提取物抗锥虫活性的研究
Heliyon. 2024 Mar 16;10(6):e28025. doi: 10.1016/j.heliyon.2024.e28025. eCollection 2024 Mar 30.
3
Boosting the Full Potential of PyMOL with Structural Biology Plugins.

本文引用的文献

1
Efficient Dimerization Disruption of Trypanothione Reductase by Triazole-phenyl-thiazoles.三氮唑-苯并噻唑高效二聚化破坏硫脒基丁氨酸还原酶。
J Med Chem. 2021 May 13;64(9):6137-6160. doi: 10.1021/acs.jmedchem.1c00206. Epub 2021 May 4.
2
An integrated exploration of pharmacological potencies of (Blume) leaves through experimental and computational modeling.通过实验和计算建模对(布卢姆)叶的药理活性进行综合探索。
Heliyon. 2020 Sep 14;6(9):e04895. doi: 10.1016/j.heliyon.2020.e04895. eCollection 2020 Sep.
3
Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.
利用结构生物学插件充分发挥 PyMOL 的潜力。
Biomolecules. 2022 Nov 27;12(12):1764. doi: 10.3390/biom12121764.
4
Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.鉴定BIK作为携带KRAS突变的微卫星稳定型结直肠癌的不良预后标志物和新型治疗靶点。
Am J Cancer Res. 2022 Nov 15;12(11):5300-5314. eCollection 2022.
通过蛋白质-蛋白质相互作用破坏剂对锥虫硫醇还原酶的拟不可逆慢结合抑制作用。
Br J Pharmacol. 2020 Nov;177(22):5163-5176. doi: 10.1111/bph.15250. Epub 2020 Oct 2.
4
The Bio3D packages for structural bioinformatics.生物 3D 结构生物信息学包。
Protein Sci. 2021 Jan;30(1):20-30. doi: 10.1002/pro.3923. Epub 2020 Aug 17.
5
Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?药物设计中的可药性和类药性概念:生物建模和预测工具是否有发言权?
J Mol Model. 2020 May 8;26(6):120. doi: 10.1007/s00894-020-04385-6.
6
Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases.针对氧化还原原生动物代谢中的关键酶——硫醇还原酶,开发治疗利什曼病和锥虫病的新药。
Molecules. 2020 Apr 21;25(8):1924. doi: 10.3390/molecules25081924.
7
Cross-docking benchmark for automated pose and ranking prediction of ligand binding.配体结合的自动构象和排序预测的交叉对接基准
Protein Sci. 2020 Jan;29(1):298-305. doi: 10.1002/pro.3784. Epub 2019 Nov 28.
8
Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.制药商:基于可药性模拟的药效团建模和命中鉴定。
Protein Sci. 2020 Jan;29(1):76-86. doi: 10.1002/pro.3732. Epub 2019 Dec 4.
9
Druggability assessment of mammalian Per-Arnt-Sim [PAS] domains using computational approaches.使用计算方法对哺乳动物的Per-Arnt-Sim [PAS]结构域进行成药潜力评估。
Medchemcomm. 2019 May 13;10(7):1126-1137. doi: 10.1039/c9md00148d. eCollection 2019 Jul 1.
10
Structure-based Druggability Assessment of Anti-virulence Targets from Pseudomonas aeruginosa.基于结构的铜绿假单胞菌抗毒力靶点药物可开发性评估。
Curr Protein Pept Sci. 2019;20(12):1189-1203. doi: 10.2174/1389203720666190417120758.